Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Leukemia Myelogenous”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00004905
What this trial is testing

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Acute Leukemia

Who this might be right for
Leukemia
Loyola University
Testing effectiveness (Phase 2)Ended earlyNCT01488253
What this trial is testing

Sirolimus/Tacrolimus Combination After HLA Matched Related Peripheral Blood Stem Cell Transplants

Who this might be right for
Acute Leukemia in RemissionMyelodysplastic SyndromesLeukemia, Myeloid, Chronic-Phase+1 more
The Korean Society of Blood and Marrow Transplantation 3
Testing effectiveness (Phase 2)Study completedNCT00004105
What this trial is testing

Combination Chemotherapy in Treating Patients With Advanced Cancer

Who this might be right for
LeukemiaLymphomaSarcoma+1 more
NYU Langone Health
Testing effectiveness (Phase 2)UnknownNCT00146913
What this trial is testing

AFR10 - Combination Therapy of Imatinib Mesylate (IM) + Alpha-2A Interferon for Chronic Phase CML Patients Resistant or Refractory to IM Used as Single Therapy for at Least One Year

Who this might be right for
Chronic Myeloid Leukemia
Hospices Civils de Lyon 30
Not applicableLooking for participantsNCT07512882
What this trial is testing

Cohort of Patients With Chronic Myelomonocytic Leukemia

Who this might be right for
LeukemiaMyelomonocytic Leukemia, Chronic
Gustave Roussy, Cancer Campus, Grand Paris 5,000
Testing effectiveness (Phase 2)Study completedNCT02472691
What this trial is testing

Azacitidine, Lenalidomide and DLI as Salvage Therapy for MDS, CMML and sAML Relapsing After Allo-HSCT

Who this might be right for
Leukemia, Myeloid, AcuteMyelodysplastic SyndromesLeukemia, Myelomonocytic, Chronic
Heinrich-Heine University, Duesseldorf 50
Early research (Phase 1)Study completedNCT00103701
What this trial is testing

BMS-354825 in Patients With Chronic Accelerated, or Blast Phase Chronic Myelogenous Leukemia or Philadelphia Positive Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia, Myeloid, Chronic-phaseLeukemia, Lymphoblastic, Acute, Philadelphia-positive
Bristol-Myers Squibb
Early research (Phase 1)Ended earlyNCT00356928
What this trial is testing

Cyclophosphamide Plus T-Cell Transplantation for Patients With Hematologic Malignancies

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 14
Testing effectiveness (Phase 2)Study completedNCT01334060
What this trial is testing

WT1 Immunity Via DNA Fusion Gene Vaccination in Haematological Malignancies by Intramuscular Injection Followed by Intramuscular Electroporation

Who this might be right for
Leukaemia (Acute)Leukaemia (Chronic)Leukaemia (Acute Myeloid)+2 more
University Hospital Southampton NHS Foundation Trust 23
Early research (Phase 1)Study completedNCT00003082
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
University of Arizona 27
Large-scale testing (Phase 3)Study completedNCT00070382
What this trial is testing

Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer

Who this might be right for
AnemiaLeukemiaLymphoma+4 more
Jonsson Comprehensive Cancer Center 14
Testing effectiveness (Phase 2)Ended earlyNCT00320190
What this trial is testing

Study of Dasatinib in Patients With Chronic Phase Chronic Myeloid Leukemia and a Suboptimal Response to Imatinib

Who this might be right for
Leukemia, Myeloid, Chronic
Bristol-Myers Squibb 52
Not applicableStudy completedNCT00920738
What this trial is testing

Metabolic Syndrome in Childhood Cancer Survivors

Who this might be right for
Brain and Central Nervous System TumorsLeukemiaLymphoma+2 more
University of Minnesota 512
Testing effectiveness (Phase 2)Ended earlyNCT00510289
What this trial is testing

Sorafenib in Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myelomonocytic, Chronic
Duke University 19
Testing effectiveness (Phase 2)Study completedNCT01527045
What this trial is testing

Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies

Who this might be right for
Aggressive Non-Hodgkin LymphomaBlasts Under 5 Percent of Bone Marrow Nucleated CellsChronic Lymphocytic Leukemia+18 more
Fred Hutchinson Cancer Center 47
Large-scale testing (Phase 3)Study completedNCT00005805
What this trial is testing

St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer

Who this might be right for
Chronic Myeloproliferative DisordersFatigueLeukemia+5 more
Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT01053494
What this trial is testing

Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated LeukemiaAngioimmunoblastic T-cell Lymphoma+84 more
Wake Forest University Health Sciences 80
Not applicableStudy completedNCT00896129
What this trial is testing

Mid-to Long-Term Outcomes in Chronic Myeloid Leukemia (CML) Patients With Complete Cytogenetic Response After Imatinib as First Line Therapy

Who this might be right for
Chronic Myeloid Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 448
Testing effectiveness (Phase 2)Ended earlyNCT00415857
What this trial is testing

Proteinase 3 PR1 Peptide Mixed With Montanide ISA-51 VG Adjuvant and Administered With GM-CSF and PEG-INTRON(R)

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 5
Testing effectiveness (Phase 2)Study completedNCT00002502
What this trial is testing

Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
Memorial Sloan Kettering Cancer Center
Next Page